# A Study of BEN301 Injection in the Treatment of Autoimmune Diseases

> **NCT07502859** · EARLY_PHASE1 · NOT_YET_RECRUITING · sponsor: **Beijing Boren Hospital** · enrollment: 24 (estimated)

## Conditions studied

- SSC RA SS IIM

## Interventions

- **BIOLOGICAL:** CD4⁺ CAR⁺ Foxp3⁺ cells
- **BIOLOGICAL:** CD4⁺ CAR⁺ Foxp3⁺ cells

## Key facts

- **NCT ID:** NCT07502859
- **Lead sponsor:** Beijing Boren Hospital
- **Sponsor class:** OTHER
- **Phase:** EARLY_PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** NOT_YET_RECRUITING
- **Start date:** 2026-03-25
- **Primary completion:** 2029-02-28
- **Final completion:** 2029-02-28
- **Target enrollment:** 24 (ESTIMATED)
- **Last updated:** 2026-04-13


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT07502859

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT07502859, "A Study of BEN301 Injection in the Treatment of Autoimmune Diseases". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT07502859. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*